Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Avinger (NASDAQ:AVGRFree Report) in a research report released on Tuesday morning. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Stock Performance

Shares of AVGR stock opened at $0.47 on Tuesday. Avinger has a 12 month low of $0.36 and a 12 month high of $4.05. The company has a market cap of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09. The firm has a fifty day moving average price of $0.47 and a 200 day moving average price of $0.61.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

See Also

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.